Lucira Health, Inc. (LHDX) financial statements (2022 and earlier)

Company profile

Business Address 1412 62ND STREET
EMERYVILLE, CA 94608
State of Incorp. DE
Fiscal Year End December 31
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments105,982
Cash and cash equivalents105,982
Receivables35,433
Inventory, net of allowances, customer advances and progress billings50,776
Inventory50,776
Prepaid expense10,274
Other current assets3,817
Total current assets:206,282
Noncurrent Assets
Operating lease, right-of-use asset2,714
Property, plant and equipment30,974
Other noncurrent assets384
Total noncurrent assets:34,072
TOTAL ASSETS:240,354
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities48,533
Accounts payable19,371
Accrued liabilities29,162
Other undisclosed current liabilities1,798
Total current liabilities:50,331
Noncurrent Liabilities
Long-term debt and lease obligation1,220
Operating lease, liability1,220
Other undisclosed noncurrent liabilities(1,220)
Total noncurrent liabilities:1,220
Total liabilities:51,551
Stockholders' equity
Stockholders' equity attributable to parent188,803
Common stock40
Additional paid in capital317,304
Accumulated deficit(128,541)
Total stockholders' equity:188,803
TOTAL LIABILITIES AND EQUITY:240,354

Income statement (P&L) ($ in thousands)

12/31/2021
Revenues93,055
Cost of revenue
(Cost of Goods and Services Sold)
(81,392)
Other undisclosed gross profit(1,439)
Gross profit:10,224
Operating expenses(75,361)
Operating loss:(65,137)
Nonoperating income327
Interest and debt expense(3)
Loss from continuing operations before equity method investments, income taxes:(64,813)
Other undisclosed income from continuing operations before income taxes3
Loss from continuing operations before income taxes:(64,810)
Income tax expense(17)
Net loss available to common stockholders, diluted:(64,827)

Comprehensive Income ($ in thousands)

12/31/2021
Net loss:(64,827)
Comprehensive loss, net of tax, attributable to parent:(64,827)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: